Stephen L. Hoerter's most recent trade in C4 Therapeutics Inc was a trade of 35,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| C4 Therapeutics Inc | Stephen L. Hoerter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 35,500 | 35,500 | - | - | Stock Option (Right to Buy) | |
| MBX Biosciences Inc. | Stephen L. Hoerter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 16,000 | 16,000 | - | - | Stock option (right to buy) | |
| MBX Biosciences Inc. | Stephen L. Hoerter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2025 | 32,000 | 32,000 | - | - | Stock option (right to buy) | |
| ORIC Pharmaceuticals Inc | Stephen L. Hoerter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 35,000 | 35,000 | - | - | Stock Option (right to buy) |